M. D. Chaplin

1.3k citations
36 papers · 1.1k · h-index 17

Impact in

    • Inflammatory mediators and NSAID effects
    • Pharmacogenetics and Drug Metabolism
    • Antibiotics Pharmacokinetics and Efficacy
    • Drug-Induced Hepatotoxicity and Protection
    • Analytical Methods in Pharmaceuticals

Papers in

    • Inflammatory mediators and NSAID effects 9
    • Pharmacogenetics and Drug Metabolism 8
    • Antibiotics Pharmacokinetics and Efficacy 3
    • Receptor Mechanisms and Signaling 3
    • Natural product bioactivities and synthesis 2

M. D. Chaplin

35 papers receiving 918 citations

Peers

M. D. Chaplin
Comparison fields: 5 of 101
  • Pharmacology 311
  • Pharmacology 361
  • Analytical Chemistry 105
  • Immunology and Allergy 55
  • Pharmaceutical Science 55
Replace Michael A. Wynalda with:
Michael A. Wynalda United States
James E. Patrick United States
Krister Gréen Sweden
B. K. Park United Kingdom
K.‐Fr. Sewing Germany
B.K. Park United Kingdom
W Dawson United Kingdom
Lester I. Harrison United States
P.J. De Schepper Belgium
Shigeo Ikegawa Japan
M. D. Chaplin relative to Michael A. Wynalda United States Michael A. Wynalda's profile →
Citations per field
00.5×1.5×2.0×
Michael A. Wynalda · 1×
Citations per year

Countries citing papers authored by M. D. Chaplin

Since Specialization
Citations

This map shows the geographic impact of M. D. Chaplin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. D. Chaplin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. D. Chaplin more than expected).

Fields of papers citing papers by M. D. Chaplin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. D. Chaplin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. D. Chaplin. The network helps show where M. D. Chaplin may publish in the future.

Co-authors

The 25 scholars most cited alongside M. D. Chaplin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. D. Chaplin Line = papers co-authored together M. D. Chaplin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1972142
2 1974107
3 198887
4 198076
5 197072
6 197671
7 197857
8 197450
9 199644
10 197342
11
Induction of drug metabolism. 3. Further information of a new P-450 hemoprotein after treatment of rats with 3-methylcholanthrene.
196939
12
Sex-dependent differences in drug metabolism in the rat. IV. Effect of morphine administration.
197434
13 198833
14 198031
15 198527
16 198524
17 197319
18 198516
19 199214
20 198112

About M. D. Chaplin

M. D. Chaplin is a scholar working on Pharmacology, Molecular Biology, Pharmacology, Physiology and Animal Science and Zoology, having authored 36 papers that have together received 1.1k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (9 papers), Pharmacogenetics and Drug Metabolism (8 papers), Animal Nutrition and Physiology (3 papers), Analytical Chemistry and Chromatography (3 papers), Receptor Mechanisms and Signaling (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Analytical Methods in Pharmaceuticals (2 papers) and Natural product bioactivities and synthesis (2 papers). The work is most often cited by research in Pharmacology (311 citations), Pharmacology (361 citations), Analytical Chemistry (105 citations), Immunology and Allergy (55 citations) and Pharmaceutical Science (55 citations). M. D. Chaplin has collaborated with scholars based in United States, Poland and Canada. Frequent co-authors include Eugene J. Segre, Richard Runkel, Enrico Forchielli, Hilli Sevelius, Gilbert J. Mannering, Gerhard Boost, C. Nerenberg, Rebecca L. Chan, Nancy Chu and William C. Cooper. Their work appears in journals such as Drug Metabolism and Disposition, Clinical Pharmacology & Therapeutics, Molecular Pharmacology, Scandinavian Journal of Rheumatology and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact